24HourWire
News from all angles
New York Post
Right
GLP-1 users face 6 rebound risks after stopping the weight-loss drugs
While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.